Welcome to the ICD‐10 code for sarcopenia

SD Anker, JE Morley… - Journal of cachexia …, 2016 - Wiley Online Library
Abstract The new ICD‐10‐CM (M62. 84) code for sarcopenia represents a major step
forward in recognizing sarcopenia as a disease. This should lead to an increase in …

[HTML][HTML] Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia

M Cesari, RA Fielding, M Pahor, B Goodpaster… - Journal of cachexia …, 2012 - Springer
Sarcopenia, the age-related skeletal muscle decline, is associated with relevant clinical and
socioeconomic negative outcomes in older persons. The study of this phenomenon and the …

[HTML][HTML] Rapid screening for sarcopenia

JE Morley, L Cao - Journal of Cachexia, Sarcopenia and Muscle, 2015 - ncbi.nlm.nih.gov
The four major comments of muscle wasting disease are cachexia, sarcopenia, malnutrition
and congenital. 1, 2 Of these, the most common is sarcopenia. 3–7 Since sarcopenia is a …

Sarcopenia

N Fuggle, S Shaw, E Dennison, C Cooper - Best Practice & Research …, 2017 - Elsevier
Sarcopenia is a condition that is characterized by loss of muscle mass, muscle strength and
muscle functional impairment with ageing. The definition of sarcopenia has been through …

[HTML][HTML] Sarcopenia and the new ICD-10-CM code: screening, staging, and diagnosis considerations

LJ Falcon, MO Harris-Love - Federal Practitioner, 2017 - ncbi.nlm.nih.gov
Sarcopenia and the New ICD-10-CM Code: Screening, Staging, and Diagnosis Considerations
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) code

L Cao, JE Morley - Journal of the American Medical Directors …, 2016 - jamda.com
As of October 1, 2016, sarcopenia will have its own International Classification of Disease,
Tenth Revision, Clinical Modification (ICD-10-CM). The assigned code will be M62. 84 and …

[HTML][HTML] Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee

PM Cawthon, M Visser, H Arai, JA Ávila-Funes… - European geriatric …, 2022 - Springer
Methods The aim of this paper is to define terms commonly related to sarcopenia to enable
standardization of these terms in research and clinical settings. The Global Leadership …

[HTML][HTML] Treatment of sarcopenia: the road to the future

JE Morley - Journal of cachexia, sarcopenia and muscle, 2018 - ncbi.nlm.nih.gov
This year, two new consensus conferences on the diagnosis and management of
sarcopenia have been published. 1, 2 Both confirm the need to screen for sarcopenia in …

[HTML][HTML] An overview of sarcopenia: facts and numbers on prevalence and clinical impact

S von Haehling, JE Morley, SD Anker - Journal of cachexia, sarcopenia …, 2010 - Springer
Human muscle undergoes constant changes. After about age 50, muscle mass decreases at
an annual rate of 1–2%. Muscle strength declines by 1.5% between ages 50 and 60 and by …

Tools in the assessment of sarcopenia

C Cooper, R Fielding, MV Visser, LJ Van Loon… - Calcified tissue …, 2013 - Springer
This review provides a framework for the development of an operational definition of
sarcopenia and of the potential end points that might be adopted in clinical trials among …